Hyperimmune Colostrum and Oral Mucositis

The Effect of Hyperimmune Colostrum on Radiation-Induce Oral Mucositis of Patients With Head and Neck Cancer

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00699569

Acronym

Mucositis

Enrollment

Registered

2008-06-18

Start date

2008-07-31

Completion date

2009-07-31

Last updated

2008-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and Neck Cancer

Keywords

hyperimmune colostrum, mucositis

Brief summary

To study the effect of daily intake of hyperimmune colostrum on prevention and treatment of oral mucositis in patients with head and neck cancer undergoing high-dose radiation.

Interventions

DIETARY_SUPPLEMENThyperimmune colostrum

hyperimmune colostrum

DIETARY_SUPPLEMENTPlacebo

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Masking

TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients with: naso-pharynx, oral cavity, oro-pharynx and advanced localized laryngeal cancer.

Exclusion criteria

* Other tumors * Non-epithelial tumors * Pregnancy * Poor functional status

Countries

Israel

Contacts

Primary ContactNachum Vaisman, Prof'

vaisman@tasmc.health.gov.il972-3-697-4807

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026